Psoriasis Health Center

News and Features Related to Psoriasis

51. Psoriasis May Improve During Pregnancy
    

    May 16, 2005 -- A new study suggests psoriasis tends to improve during pregnancy and the relief is linked to an increase in estrogen levels. "The number of patients with psoriasis who improve in pregnancy is double the number of patients who worsen in pregnancy," Jenny E. Murase, MD, and colleagues

    Read Full Article
52. Potential Target for Treating Psoriasis Found
    

    Dec. 13, 2004 -- The key to stopping the skin disease psoriasis may be a molecule called Stat3 --a potential new target for psoriasis treatment. Stat3 is found in most human skin cells that make up psoriasis patches, say scientists including Shigetoshi Sano of the University of Texas M.D. Anderson C

    Read Full Article
53. Humira Improves Life With Psoriasis
    

    Aug. 4, 2004 -- Three months ago, the rheumatoid arthritis drug Enbrel became the first drug of its kind to win FDA approval for the treatment of psoriasis. Now, early research suggests that the similarly acting arthritis drug Humira is also highly effective in treating the debilitating skin conditi

    Read Full Article
54. FDA Approves Enbrel for Psoriasis
    

    May 3, 2004 -- Enbrel now joins Amevive and Raptiva as one of the first biologic drugs to be approved for the treatment of psoriasis.   The FDA approved Enbrel on April 30 for the treatment of adults 18 and older with chronic, moderate to severe psoriasis. Psoriasis is an incurable skin condition in

    Read Full Article
55. Psoriasis Takes Toll on Mind as Well as Skin
    

    Feb. 9, 2004 -- The pain people with psoriasis feel is more than skin deep. New research shows that many people with the skin condition suffer from emotional pain that outweighs the physical aspects of the disease. For example, three-fourths of people with severe psoriasis and about half of people w

    Read Full Article
56. 2 New Drugs Relieve Psoriasis Itch, Scaling
    

    Dec. 16, 2003 -- Two new psoriasis treatments look promising, helping relieve pain, itch, and frequency of scaling. Studies of the two news psoriasis treatments -- Amevive and Raptiva -- show both drugs provided significant relief of psoriasis symptoms and disease. Both drugs target immune system ce

    Read Full Article
57. New Psoriasis Treatments Work
    

    Nov. 19, 2003 -- Not so long ago, psoriasis sufferers had few options. Now three already-available drugs offer relief from the agonizing skin disease. The new drugs are Enbrel, Raptiva, and Amevive. All are "biological" drugs -- they use recent scientific breakthroughs to target specific body functi

    Read Full Article
58. Raptiva Approved for Psoriasis Treatment
    

    Oct. 28, 2003 -- Raptiva is the newest drug to gain FDA approval for chronic moderate to severe psoriasis. It's the second so-called biologic agent to treat the autoimmune problems at the heart of psoriasis. Raptiva -- generic name, efalizumab -- is a designer antibody. It's designed to throw a monk

    Read Full Article
59. Psoriasis Treatments Face Off
    

    Aug. 13, 2003 -- Two common drugs used to treat moderate to severe psoriasis are likely to produce similar results in people who suffer from the skin disorder, according to a new study. But researchers say although the psoriasis treatments, methotrexate and cyclosporine, are equally effective, each

    Read Full Article
60. New Psoriasis Treatment Offers Hope
    

    June 16, 2003 -- A new psoriasis treatment that gets right to the core of psoriasis provides lasting relief for people who have run out of options. A new study shows weekly injections of the drug Amevive can significantly reduce the pain, itching, inflammation, and other symptoms of psoriasis withou

    Read Full Article